Intravenous immunoglobulins as first-line therapy for IgLON5 encephalopathy

J Neurol. 2019 Apr;266(4):1031-1033. doi: 10.1007/s00415-019-09221-3. Epub 2019 Feb 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Brain Diseases / genetics*
  • Brain Diseases / immunology
  • Brain Diseases / therapy*
  • Cell Adhesion Molecules, Neuronal / genetics*
  • Chorea / genetics
  • Chorea / immunology
  • Chorea / therapy
  • Cognitive Dysfunction / genetics
  • Cognitive Dysfunction / immunology
  • Cognitive Dysfunction / therapy
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Immunologic Factors / therapeutic use*
  • Male
  • Middle Aged
  • Phenotype

Substances

  • Cell Adhesion Molecules, Neuronal
  • IgLON5 protein, human
  • Immunoglobulins, Intravenous
  • Immunologic Factors